203 related articles for article (PubMed ID: 20482510)
1. Acamprosate: how, where, and for whom does it work? Mechanism of action, treatment targets, and individualized therapy.
Kiefer F; Mann K
Curr Pharm Des; 2010; 16(19):2098-102. PubMed ID: 20482510
[TBL] [Abstract][Full Text] [Related]
2. Acamprosate: recent findings and future research directions.
Mann K; Kiefer F; Spanagel R; Littleton J
Alcohol Clin Exp Res; 2008 Jul; 32(7):1105-10. PubMed ID: 18540918
[TBL] [Abstract][Full Text] [Related]
3. [Acamprosate--a novel treatment for alcoholism].
Golovko SI; Zefirov SIu; Golovko AI; Shpilenia LS; Nekrasov IuA
Eksp Klin Farmakol; 2000; 63(3):70-3. PubMed ID: 10934602
[TBL] [Abstract][Full Text] [Related]
4. Acamprosate in alcohol dependence: how does it work?
Littleton J
Addiction; 1995 Sep; 90(9):1179-88. PubMed ID: 7580816
[TBL] [Abstract][Full Text] [Related]
5. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
Wilde MI; Wagstaff AJ
Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
[TBL] [Abstract][Full Text] [Related]
6. Acamprosate.
Kennedy WK; Leloux M; Kutscher EC; Price PL; Morstad AE; Carnahan RM
Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):363-80. PubMed ID: 20163323
[TBL] [Abstract][Full Text] [Related]
7. Acamprosate produces its anti-relapse effects via calcium.
Spanagel R; Vengeliene V; Jandeleit B; Fischer WN; Grindstaff K; Zhang X; Gallop MA; Krstew EV; Lawrence AJ; Kiefer F
Neuropsychopharmacology; 2014 Mar; 39(4):783-91. PubMed ID: 24081303
[TBL] [Abstract][Full Text] [Related]
8. Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.
Scott LJ; Figgitt DP; Keam SJ; Waugh J
CNS Drugs; 2005; 19(5):445-64. PubMed ID: 15907154
[TBL] [Abstract][Full Text] [Related]
9. The development of acamprosate as a treatment against alcohol relapse.
Kufahl PR; Watterson LR; Olive MF
Expert Opin Drug Discov; 2014 Nov; 9(11):1355-69. PubMed ID: 25258174
[TBL] [Abstract][Full Text] [Related]
10. The clinical pharmacology of acamprosate.
Kalk NJ; Lingford-Hughes AR
Br J Clin Pharmacol; 2014 Feb; 77(2):315-23. PubMed ID: 23278595
[TBL] [Abstract][Full Text] [Related]
11. Acamprosate.
Nurs Times; 2005 Sep 6-12; 101(36):35. PubMed ID: 16163934
[No Abstract] [Full Text] [Related]
12. Pharmacology of acamprosate: an overview.
Zornoza T; Cano MJ; Polache A; Granero L
CNS Drug Rev; 2003; 9(4):359-74. PubMed ID: 14647529
[TBL] [Abstract][Full Text] [Related]
13. Acamprosate for the adjunctive treatment of alcohol dependence.
Overman GP; Teter CJ; Guthrie SK
Ann Pharmacother; 2003; 37(7-8):1090-9. PubMed ID: 12841823
[TBL] [Abstract][Full Text] [Related]
14. The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence.
Mason BJ; Heyser CJ
Expert Opin Drug Saf; 2010 Jan; 9(1):177-88. PubMed ID: 20021295
[TBL] [Abstract][Full Text] [Related]
15. Potential neuroprotective effects of acamprosate.
Koob GF; Mason BJ; De Witte P; Littleton J; Siggins GR
Alcohol Clin Exp Res; 2002 Apr; 26(4):586-92. PubMed ID: 11981137
[TBL] [Abstract][Full Text] [Related]
16. Acamprosate for the treatment of alcohol dependence.
Boothby LA; Doering PL
Clin Ther; 2005 Jun; 27(6):695-714. PubMed ID: 16117977
[TBL] [Abstract][Full Text] [Related]
17. Acamprosate: a prototypic neuromodulator in the treatment of alcohol dependence.
Mason BJ; Heyser CJ
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):23-32. PubMed ID: 20201812
[TBL] [Abstract][Full Text] [Related]
18. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
[TBL] [Abstract][Full Text] [Related]
19. Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond.
Ragia G; Manolopoulos VG
Curr Pharm Biotechnol; 2017; 18(3):221-230. PubMed ID: 28240173
[TBL] [Abstract][Full Text] [Related]
20. Does acamprosate improve reduction of drinking as well as aiding abstinence?
Chick J; Lehert P; Landron F;
J Psychopharmacol; 2003 Dec; 17(4):397-402. PubMed ID: 14870951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
